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Eliminating barriers to adequate pain control and decreasing disparities in the
management of pain is increasingly on the international health policy radar. The
World Health Organization’s (WHO) published guidelines for physicians and
pharmacists regarding administration of pain treatment have been adopted by
professional provider associations world wide.1 The WHO Collaborating Center for
Policy and Communications in Cancer Care works internationally with governmental
and nongovernmental organizations and individuals to decrease barriers to pain relief
through active demonstrations, networking, and policy initiatives. In 2003, legislation
was introduced (H.R.1863) to recognize pain as a priority health problem in the
United States. The “National Pain Care Policy Act” calls for the establishment of a
National Center for Pain and Palliative Care Research at the National Institutes
of Health and the development of six regional pain research centers throughout the
country. At the level of patient care, The Joint Commission on Accreditation of
Healthcare Organizations (JCAHO) has clearly addressed the imperative for
accredited hospitals and other healthcare settings to competently assess and
manage pain.2
The Einstein Center for Urban Health Policy and Research and the Einstein Cancer
Center in Philadelphia are collaborating on a project, funded by the Nathan
Cummings Foundation, to address barriers to optimal pain control for low to
moderate income patients with cancer pain.3 Patients with moderate to severe pain
are identified from their self-rated pain scores Consenting patients are interviewed in
greater depth about their level of pain and their beliefs and attitudes towards pain.
Eligibility for relevant pharmaceutical ‘safety net’ programs, which provide vouchers
for the necessary medication, is also assessed at this time. A nurse program
manager is available to provide education and counseling to participants when issues
are identified during the assessment phase.
To date, 40 patients have been enrolled in the program. Primary patient attitudinal
beliefs related in the under treatment of pain include: the well-documented fear of
addiction; fear that pain is a sign of disease progression, which results in their not
wanting to talk about it with their physician; troubling side effects such as
constipation; and the desire to save medication for when they “really need it.”
Fifteen (38 %) participants reported not having the financial ability to pay for their
medications. Co-payments were reported from a low of $6.00 a prescription to a high
of $87.00 per prescription. For patients covered by Medicaid, there can be monthly
caps on number of pills and refills, and prescriptions.4 Even other insurance plans
can cause similar barriers to receiving appropriate pain treatment, including different
coverage for pain medications with modest to substantial co-payments, and other
limitations for non-hospitalized, community dwelling patients.
An important objective of the collaborative project is to facilitate enrollment for these
patients into pharmaceutical safety net programs. Application processes for
these programs often require extensive documentation that can challenge even the
seasoned health professionals. We discovered that safety net programs offered by
the pharmaceutical companies that produce the most commonly prescribed long
acting opiods were available only to the uninsured, or had been discontinued
because a generic form of the drug had become available. Because our low-income
patients were covered by Medicaid or were Medicaid eligible, the pharmaceutical
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safety net programs were not available to them. Our interim finding that safety net
programs were not an option for our patients led us to explore the potential use of
Methadone, a highly effective, low cost analgesic. Although Methadone has been
used successfully in severe pain, close supervision and dosage adjustment is
required and it is not clear that this is a viable option for our patient population at
this time. The program continues to consider other options and works towards
reducing the existing barriers to pain control for those with limited income. It is clear
that Medicaid must reevaluate current caps and other limitations related to
prescription pain medication. Other initiatives to allow patient access to needed
pain medications are crucial to reaching pain management goals. Additionally, we
find that counseling patients on attitudinal barriers is an important and often
neglected component of the field of pain management.
Pain policies and guidelines emphasize pain as a profound human experience. The
clinical application of pain policies requires continued efforts at multiple levels to
ensure we meet our humanitarian obligation as health care providers to assess
and manage pain optimally across all patient populations.
For more information about our program, contact phippst@einstein.edu.
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